ロード中...
Pyrotinib versus trastuzumab emtansine for HER2-positive metastatic breast cancer after previous trastuzumab and lapatinib treatment: a real-world study
BACKGROUND: To compare the efficacy and safety of pyrotinib and trastuzumab emtansine (T-DM1) in patients who experienced disease progression on trastuzumab and lapatinib treatment. METHODS: This was a real-world study that included cases of metastatic breast cancer (MBC) with trastuzumab and lapati...
保存先:
| 出版年: | Ann Transl Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7867920/ https://ncbi.nlm.nih.gov/pubmed/33569405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-4054 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|